February 5, 2018 (Gainesville, FL) – Curant Health was named to the University of Florida’s 2018 Gator100 during a ceremony February 2 at the University’s J. Wayne Reitz Union Grand Ballroom. Sponsored by the UF Alumni Association, in partnership with the UF Entrepreneurship & Innovation Center, the Gator100 recognizes the 100 fastest-growing businesses owned or […]
January 30, 2018 – Curant Health Director of Clinical Services, Vickie Andros, PharmD, and Senior Director of Commercial Strategy & Performance, Jake Caines, in PharmExec.com. Building awareness for life-changing pharmaceutical therapies is a primary focus of the brand team and is an activity at which brand teams are extremely adept. However, investments in activities that successfully […]
Jan 25, 2018 - Marc O'Connor, Curant Health COO in PharmExec.com It was widely reported in early January 2018 that, for the first time in history, healthcare became the United States’ largest source of jobs, surpassing the manufacturing and retail sectors. For many, the surprise was not that it happened, but that it happened so […]
January 16, 2018 (Atlanta, GA) - In Q4 2017, Curant Health added four new partners to its family of 340B covered entities it serves through its personalized medication management and specialty pharmacy fulfillment services. It also expanded its relationship with Chattanooga Cares to provide PrEP therapy for HIV-negative patients. The four new partners who will […]
Now more than ever, 340B covered entities must ensure they are providing high value, critical care for underserved populations in a way that stands up to scrutiny. What will we learn at 340B Winter 2018?
January 12, 2018 - Curant Health Director of Clinical Services, Vickie Andros, PharmD, and Senior Director of Commercial Strategy & Performance, Jake Caines, in PharmExec.com Numerous strategies and tactics are implemented by pharmaceutical manufacturer brand teams to drive awareness. According to Kantar Media, pharmaceutical advertising exceeded $6 billion in 2016. However, value for pharma organizations […]
What pharma can’t say about outcomes based contracts at JPMorgan 2018. Hint: It’s the “P” word.
December 12, 2017 - Curant Health COO Marc O'Connor in Becker’s Hospital Review Senior leadership of integrated delivery networks and health systems believe there is value in in-house specialty pharmacy, based on numerous, ongoing attempts to create their own. According to Adam Fein, 47% of hospitals with more than 600 beds operated a specialty pharmacy […]
Here's a hint: It’s mostly about why ACO leadership should attend FLAACOs 2018. CMS recently reported that more than 400 ACOs participating in the Medicare Shared Savings Program generated $652 million in gross savings in 2016. While that is an encouraging number to be sure, some ACOs still struggle to identify and implement investment and […]
By definition, accountable care organizations are the tip of the spear in the transition from fee-for-service to value-based care by tying payments to quality metrics and the cost of care. Did you know there are 16 quality performance standards by which ACOs are evaluated tied to medication adherence, education and the medication management team? Through […]
